Authors Response : Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19
| Errataetall: |
CommentOn: Intern Med. 2021 Nov 15;60(22):3559-3567. - PMID 34511566 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Internal medicine (Tokyo, Japan) - 61(2022), 15 vom: 01. Aug., Seite 2401 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ishiyama, Hiroyuki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 02.08.2022 Date Revised 17.09.2022 published: Print-Electronic CommentOn: Intern Med. 2021 Nov 15;60(22):3559-3567. - PMID 34511566 Citation Status MEDLINE |
|---|
| doi: |
10.2169/internalmedicine.8954-21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335572456 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335572456 | ||
| 003 | DE-627 | ||
| 005 | 20231225230144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2169/internalmedicine.8954-21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1118.xml |
| 035 | |a (DE-627)NLM335572456 | ||
| 035 | |a (NLM)35022358 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ishiyama, Hiroyuki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Authors Response |b Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.08.2022 | ||
| 500 | |a Date Revised 17.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Intern Med. 2021 Nov 15;60(22):3559-3567. - PMID 34511566 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a infectious diseases | |
| 650 | 4 | |a intensive and critical care | |
| 650 | 4 | |a neurology | |
| 650 | 4 | |a post-COVID-19 syndrome | |
| 700 | 1 | |a Ishii, Junko |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshimura, Hajime |e verfasserin |4 aut | |
| 700 | 1 | |a Ohara, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kohara, Nobuo |e verfasserin |4 aut | |
| 700 | 1 | |a Kawamoto, Michi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g 61(2022), 15 vom: 01. Aug., Seite 2401 |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2022 |g number:15 |g day:01 |g month:08 |g pages:2401 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.8954-21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2022 |e 15 |b 01 |c 08 |h 2401 | ||